Transcutaneous bilirubinometry versus total serum bilirubin measurement for newborns
Referencias
Additional references
American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114(1):297–316. [PUBMED: 15231951]
Akman I, Arika Ç, Bilgen H, KalaCa S, Özek E. Transcutaneous Measurement of Bilirubin by Icterometer During Phototherapy on a Bilibed. Turkish Journal of Medical Sciences 2000;32:165‐8.
Barrington KJ, Sankaran K. Canadian Paediatric Society; Fetus and Newborn Committee. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants. Paediatric Child Health 2007;12(Suppl B):1B‐12B.
Bhutani VK, Vilms RJ, Hamerman‐Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. Journal of Perinatology 2010;30 Suppl:S6‐15. [PUBMED: 20877410]
Boo NY, Ishak S. Prediction of severe hyperbilirubinaemia using the Bilicheck transcutaneous bilirubinometer. Journal of Paediatrics and Child Health 2007;43(4):297‐302. [DOI: 10.1111/j.1440‐1754.2007.01062.x]
Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, Tilford JM. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988‐2005. Pediatrics 2009;123(2):524‐32. [PUBMED: 19171618]
Dai J, Krahn J, Parry DM. Clinical impact of transcutaneous bilirubinometry as an adjunctive screen for hyperbilirubinemia. Clinical Biochemistry 1996;29(6):581‐6. [PUBMED: 8939407]
Dai J, Parry DM, Krahn J. Transcutaneous bilirubinometry: its role in the assessment of neonatal jaundice. Clinical Biochemistry 1997;30(1):1‐9. [DOI: 10.1016/S0009‐9120(96)00131‐2]
De Luca D, Zecca E, Zuppa AA, Romagnoli C. The joint use of human and electronic eye: visual assessment of jaundice and transcutaneous bilirubinometry. Turkish Journal of Pediatrics 2008;50(5):456‐61.
Donzelli G, Pratesi S. Transcutaneous bilirubinometry in healthy preterm newborns. Clinical Biochemistry 2000;33(6):505‐8. [PUBMED: 11074244]
Ebbesen F, Andersson C, Verder H, GrytterC, Pedersen‐Bjergaard L, Petersen JR, et al. Extreme hyperbilirubinaemia in term and near‐term infants in Denmark. Acta Paediatrica 2005;94(1):59‐64. [PUBMED: 15858962]
el‐Beshbishi SN, Shattuck KE, Mohammad AA, Petersen JR. Hyperbilirubinemia and transcutaneous bilirubinometry. Clinical Chemistry 2009;55(7):1280‐7. [PUBMED: 19443565]
Grohmann K, Roser M, Rolinski B, Kadow I, Müller C, Goerlach‐Graw A, et al. Bilirubin measurement for neonates: comparison of 9 frequently used methods. Pediatrics 2006;117(4):1174‐83. [DOI: 10.1542/peds.2005‐0590]
Harrison SP, Barlow IM. Three direct spectrophotometric methods for determination of total bilirubin in neonatal and adult serum, adapted to the Technicon RA‐1000 analyzer. Clinical Chemistry 1989;35(9):1980‐6. [PUBMED: 2776331]
Higgins T, Eckfeldt JH, Barton JC, Doumas BT. Hemoglobin, iron and bilirubin. In: Burtis CA, Ashwood ER, Bruns DE editor(s). Tietz textbook of clinical chemistry and molecular diagnostics. 4th Edition. Missouri: Elsevier Saunders, 2012:985‐1030.
Jangaard K, Curtis H, Goldbloom R. Estimation of bilirubin using BiliChektrade mark, a transcutaneous bilirubin measurement device: Effects of gestational age and use of phototherapy. Paediatrics & Child Health 2006;11(2):79‐83.
Johnson LH, Bhutani VK, Brown AK. System‐based approach to management of neonatal jaundice and prevention of kernicterus. Journal of Pediatrics 2002;140(4):396‐403.
Karen T, Bucher HU, Fauchère JC. Comparison of a new transcutaneous bilirubinometer (Bilimed®) with serum bilirubin measurements in preterm and full term infants. BMC Pediatrics 2009;9:70. [DOI: 10.1186/1471‐2431‐9‐70]
Kazmierczak SC, Robertson AF, Catrou PG, Briley KP, Kreamer BL, Gourley GR. Direct spectrophotometric method for measurement of bilirubin in newborns: comparison with HPLC and an automated diazo method. Clinical Chemistry 2002;48(7):1096‐7. [PUBMED: 12089180]
Kazmierczak SC, Robertson AF, Briley KP, Kreamer B, Gourley GR. Transcutaneous measurement of bilirubin in newborns: comparison with an automated Jendrassik‐Grof procedure and HPLC. Clinical Chemistry 2004;50(2):433‐5. [PUBMED: 14752014]
Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Archives of Disease in Childhood 2005;90(4):415‐21. [DOI: 10.1136/adc.2004.060079]
Knüpfer M, Pulzer F, Braun L, Heilmann A, Robel‐Tillig E, Vogtmann C. Transcutaneous bilirubinometry in preterm infants. Acta Paediatrica 2001;90:899‐903. [DOI: 10.1080/08035250152509636]
Lauer BJ, Spector ND. Hyperbilirubinemia in the Newborn. Pediatrics in Review. Pediatrics in Review 2011;32(8):341‐9. [PUBMED: 21807875]
Lo SF, Doumas BT. The status of bilirubin measurements in U.S. laboratories: why is accuracy elusive?. Seminars in Perinatology 2011;35(3):141‐7. [PUBMED: 21641487]
Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and Presenting Results. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. Available from srdta.cochrane.org.
Madsen LP, Rasmussen MK, Bjerregaard LL, Nohr SB, Ebbesen F. Impact of blood sampling in very preterm infants. Scandinavian journal of clinical and laboratory investigation 2000;60(2):125‐32. [PUBMED: 10817399]
Maisels MJ, Kring E. Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics 1997;99:599‐601.
Manning D, Todd P, Maxwell M, Platt M. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Archives of Disease in Childhood. Fetal and Neonatal Edition 2007;92(5):342‐6. [PUBMED: 17074786 ]
Nair PA, Al Khusaiby SM. Kernicterus and G6PD deficiency‐‐a case series from Oman. Journal of Tropical Pediatrics 2003;49(2):74‐7. [PUBMED: 12729287]
Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World Journal of Pediatrics 2009;5(1):51‐5. [PUBMED: 19172333]
Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982‐90. [PUBMED: 16168343]
Samiee‐Zafarghandy S, Feberova J, Williams K, Yasseen AS, Perkins SL, Lemyre B. Influence of skin colour on diagnostic accuracy of the jaundice meter JM 103 in newborns. Archives of Disease in Childhood. Fetal and Neonatal Edition 2014;99(6):F480‐4.
Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Canadian Medical Association Journal 2006;175(6):587‐90. [PUBMED: 16966660]
Wainer S, Parmar SM, Allegro D, Rabi Y, Lyon ME. Impact of a transcutaneous bilirubinometry program on resource utilization and severe hyperbilirubinemia. Pediatrics 2012;129(1):77‐86.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, DeeksJJ, Reitsma JB, et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529–36. [PUBMED: 22007046]
Woodgate P, Jardine LA. Neonatal jaundice: phototherapy. (Systematic review 319. BMJ Clinical Evidence). www.clinicalevidence.bmj.com/x/systematic‐review/0319/overview.html (accessed 22 February 2016).
Yamanouchi I, Yamauchi Y, Igarashi I. Transcutaneous bilirubinometry: preliminary studies of noninvasive transcutaneous bilirubin meter in the Okayama National Hospital. Pediatrics 1980;65(2):195‐202. [PUBMED: 7354964]
| [Study ID] | First author, year of publication |
| Type of study | Journal article, unpublished data |
| Participants | Sample size Country of study Baseline characteristics (gestational age, postnatal age, race, body weight) |
| Study design | Retrospective/prospective design Sample (consecutive, random or unclear) |
| Study criteria | Inclusion criteria Exclusion criteria |
| Reference standard | Name of assay/manufacturer Name of instrument Cut‐off values Time between reference standard performance and TcB measurement Blinding of operator to TcB result |
| Index test | Name of device Cut‐off values Operator training site of measurement (forehead, sternum) |
| Target condition | Universal screening of newborns for hyperbilirubinaemia Diagnostic determination of hyperbilirubinaemia in visibly jaundiced newborns Monitoring of bilirubin in newborns on therapy for hyperbilirubinaemia |
| Data | Number of true positives and false positives Number of true negatives and false negatives Number of undetermined/uninterpretable results Sensitivity and specificity of index test Number of missing results for index test Number of missing results for reference standard |
| Notes | Source of funding (whether any author is affiliated with the manufacturer of the index test; the study was directly funded by the manufacturer; authors reported conflicts of interests related to the manufacturer or other funding sources) |
Figuras y tablas -
Table 1. Data from each study
